Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-05-12

Clinical Trial Update: Allogeneic Mesenchymal Stem Cells for Osteoarthritis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating allogeneic mesenchymal stem cells for osteoarthritis of the knee has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Allogeneic mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: Stempeutics Research Pvt Ltd | Conditions: Osteoarthritis of Knee Joint | Phase 2 | Status: COMPLETED